Literature DB >> 7611878

Expression of the nucleoprotein of rabies virus in Escherichia coli and mapping of antigenic sites.

H Goto1, N Minamoto, H Ito, T R Luo, M Sugiyama, T Kinjo, A Kawai.   

Abstract

Investigations were performed to delineate the antigenic sites I and IV of rabies virus nucleoprotein (N), the former of which is well conserved among the rabies and rabies-related viruses. The N cDNA of the RC-HL strain was inserted into an expression vector pET3a, with which the E. coli BL21(DE3) was transformed. Upon induction with isopropyl-1-thio-beta-D-galactoside, the transformants produced a protein with a size (56 k-Da) almost identical to that of the authentic N protein. The protein also reacted with a panel of our N protein-specific monoclonal antibodies (N-MAbs) including the antibodies against the antigenic sites I and IV. By using the cDNA, various deletion mutants were generated and expressed in E. coli to examine the reactivity of mutant proteins with N-MAbs by Western blot analysis. Deletion of the C-terminal 67 amino acid residues did not abolish their reactivity with any of the N-MAbs specific for the sites I and IV. When 91 residues or more were deleted from the C-terminus, however, the protein lost the reactivity, indicating that the antigenic sites I and IV are mapped to a small region which is comprised of at most 24 amino acid residues from positions 360 to 383. Comparison of the 24-amino acid sequence with the corresponding region of N protein of several other Lyssavirus strains suggests that the antigenic site I is mapped to positions 360 to 369.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611878     DOI: 10.1007/BF01315415

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  20 in total

1.  Antigenic sites on the ERA rabies virus nucleoprotein and non-structural protein.

Authors:  M Lafon; T J Wiktor
Journal:  J Gen Virol       Date:  1985-10       Impact factor: 3.891

2.  Linear and conformation-dependent antigenic sites on the nucleoprotein of rabies virus.

Authors:  N Minamoto; H Tanaka; M Hishida; H Goto; H Ito; S Naruse; K Yamamoto; M Sugiyama; T Kinjo; K Mannen
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

3.  Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein.

Authors:  H C Ertl; B Dietzschold; M Gore; L Otvos; J K Larson; W H Wunner; H Koprowski
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  Localization and immunological characterization of antigenic domains of the rabies virus internal N and NS proteins.

Authors:  B Dietzschold; M Lafon; H Wang; L Otvos; E Celis; W H Wunner; H Koprowski
Journal:  Virus Res       Date:  1987-08       Impact factor: 3.303

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Molecular diversity of the Lyssavirus genus.

Authors:  H Bourhy; B Kissi; N Tordo
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

7.  Nucleotide sequence of the nucleoprotein gene of the RC.HL strain of rabies virus, a seed strain used for animal vaccine production in Japan.

Authors:  H Goto; N Minamoto; H Ito; M Sugiyama; T Kinjo; K Mannen; K Mifune; A Kawai
Journal:  Virus Genes       Date:  1994-03       Impact factor: 2.332

8.  Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein.

Authors:  M Fekadu; J W Sumner; J H Shaddock; D W Sanderlin; G M Baer
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

9.  Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19.

Authors:  K K Conzelmann; J H Cox; L G Schneider; H J Thiel
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

10.  Resistance of mice vaccinated with rabies virus internal structural proteins to lethal infection.

Authors:  Y Takita-Sonoda; H Fujii; K Mifune; Y Ito; M Hiraga; A Nishizono; K Mannen; N Minamoto
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more
  9 in total

1.  Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice.

Authors:  N Ito; M Takayama; K Yamada; M Sugiyama; N Minamoto
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Development of monoclonal antibodies suitable for rabies virus antibody and antigen detection.

Authors:  Vishal Chander; R P Singh; P C Verma
Journal:  Indian J Virol       Date:  2012-09-26

Review 3.  Superantigen related to rabies.

Authors:  M Lafon; A Galelli
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Prokaryotic Expression, Purification, and Polyclonal Antibody Production of a Truncated Recombinant Rabies Virus L Protein.

Authors:  Jinyang Zhang; Zian Jin; Tao Sun; Yan Jiang; Qinqin Han; Yuzhu Song; Qiang Chen; Xueshan Xia
Journal:  Iran J Biotechnol       Date:  2015-06       Impact factor: 1.671

5.  A new competitive enzyme-linked immunosorbent assay demonstrates adequate immune levels to rabies virus in compulsorily vaccinated Japanese domestic dogs.

Authors:  M Sugiyama; R Yoshiki; Y Tatsuno; S Hiraga; O Itoh; K Gamoh; N Minamoto
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

6.  Cloning and expression of fragment of the rabies virus nucleoprotein gene in Escherichia coli and evaluation of antigenicity of the expression product.

Authors:  K Tursunov; A Begaliyeva; B Ingirbay; K Mukanov; E Ramanculov; A Shustov; K Mukantayev
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

7.  Mapping of antigenic sites on the major inner capsid protein of avian rotavirus using an Escherichia coli expression system.

Authors:  H Ito; N Minamoto; H Goto; T R Luo; M Sugiyama; T Kinjo
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Genomic analysis of matrix gene and antigenic studies of its gene product (M1) of a swine influenza virus (H1N1) causing chronic respiratory disease in pigs.

Authors:  M Welman; D J Arora
Journal:  Virus Genes       Date:  2000-10       Impact factor: 2.332

9.  Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes.

Authors:  J Weyer; I V Kuzmin; C E Rupprecht; L H Nel
Journal:  Epidemiol Infect       Date:  2007-06-22       Impact factor: 2.451

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.